() - The number of states with the highest obesity rates declined in 2024, while Nevada’s obesity epidemic deepened. Last ...

While this coincides with an uptick in GLP-1 drug use, some experts told Newsweek they don't think they are having a major ...

The fight against obesity has become one of the greatest medical challenges of the 21st century, with the World Health Organisation (WHO) warning that over one billion people worldwide including 880 ...

Why do some U.S. states have obesity rates above 40%? Here’s what regional trends, social factors and health policies reveal.

MAHA advocates are skeptical of President Donald Trump's deal to lower drug prices for GLP-1 anti-obesity drugs.

President Donald Trump has unveiled a deal with drugmakers Eli Lilly and Novo Nordisk to reduce prices for their obesity ...

"I am delighted that some of our most vulnerable populations may now have access to a tool to manage a disease which has plagued American society for a long time. However, I am concerned that when ...

Trump secures a major deal with Eli Lilly and Novo Nordisk to cut obesity drug costs as Medicare expands coverage for ...

The UN humanitarian relief chief, Tom Fletcher, has sounded the alarm over rising violence in the occupied West Bank, where ...

People in the United States are obsessed with dieting and body size. That may be due to the fact that 40.3% of adults have ...

GLP-1s are about to get more affordable in the United States, thanks to a new deal announced Thursday, Nov. 6 by the Trump ...

President Donald Trump announced major GLP-1 drug price cuts with Eli Lilly and Novo Nordisk, reducing costs for Ozempic and Wegovy.